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l In an attempt to assess the structural requirements for the musearlnie receptor selectivity of 
hexahydro-diphenidol (hexahydro-difenidol) and hexahydro-sila-diphenidol (hexahydro-sila-difeni-
dol), a serles of structurally related C/Si pairs were investigated, along with atropine, pirenzepine 
and methoctramine, for their binding affinities in NB-OK 1 cells as well as in rat heart and panc-
reas. 
2 The action of these antagonists at musearlnie receptors mediating negative inotropic responses 
in guinea-pig atrla and ileal contractions has also been assessed. 
3 Antagonist binding data indicated that NB-OK 1 cells (M 1 type) as weil as rat heart (cardiac 
type) and pancreas (glandularjsmooth muscle type) possess different muscarinic receptor subtypes. 
4 A highly significant correlation was found between the binding affinities of the antagonists to 
musearlnie receptors in rat heart and pancreas, respectively, and the affinities to muscarinic recep-
tors in guinea-pig atria and ileum. This implies that the musearlnie binding sites in rat heart and the 
receptors in guinea-pig atrla are essentially similar, but different from those in pancreas and ileum. 
5 The antimuscarinic potency of hexahydro-diphenidol and hexahydro-sila-diphenidol at the three 
subtypes was inftuenced differently by structural modifications (e.g. quaternization). Different selec-
tivity profiles for the antagonists were obtained, which makes these compounds useful tools to 
investigate further muscarinic receptor heterogeneity. lndeed, the tertiary analogues hexahydro-
diphenidol (HHD) and hexahydro-sila-diphenidol (HHSiD) bad an M1 = glandularjsmooth 
muscle > cardiac selectivity profile, whereas the quaternary analogues HHD methiodide and 
HHSiD methiodide were M 1 preferring (M 1 > glandularjsmooth muscle, cardiac). 
Introcluction 
Three muscarinic receptors with different selectivities 
for antagonists have been described in binding 
sturlies as weil as in in vitro and in vivo pharmaco-
logical assays. M 1 receptors are above all found in 
the nervous system and are characterized by a high 
"tffinity for pirenzepine (Hammer et al., 1980; Bird-
sall et al., 1980; Brown et al., 1980; Hammer & Gia-
chetti, 1982; Lambrecht et al., 1988b). M1 receptors, 
which show low affinity for pirenzepine, have been 
further subdivided into cardiac type and glandularj 
smooth muscle subtypes by use of selective antago-
1 Author for correspondcnce. 
nists such as 4-diphenylacetoxy-N-methyl-piperidine 
methiodide (4-DAMP) (Barlow et al., 1976; Wael-
broeck et al., 1987a; Doods et al., 1987), hexahydro-
diphenidol (hexahydro-difenidol) and 
hexahydro-sila-diphenidol (hexahydro-sila-difenidol) 
(M utschler & Lambrecht, 1984; Waelbroeck et al., 
1987b; Lambrecht et al., 1988a, c), AF-DX 116 
(Hammer et al., 1986; Giachetti et al., 1986; Doods 
et al., 1987) and methoctramine (Melchiorre et al., 
1987; Michel & Whiting, 1988). 
Among these selective musearlnie antagonists, 
hexahydro-diphenidol (Ja) and hexahydro-sila-di-
phenidol (Jb) have been shown to have high affinity 
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2a/2b 
5a/5b 6a/6b 
a: EI = C, b: b: EI = Si 
Figure 1 Structural formula of antagonists studied: demethyl-bexocyclium (Ja), demethyl-sila-hexocyclium (lb), 
bexocyclium (2a), sila-hexocyclium (2b), hexahydro-dipbenidol (Ja), hexabydro-sila-dipbenidol (3b), N-metbyl-
bexabydro-dipbenidol (4a), N-methyl-bexabydro-sila-dipbenidol (4b), procyclidine (5a), sila-procyclidine (5b), tri-
cyclamol (6a), and sila-tricyclamol (6b). 
for M 1 receptors in neuronal tissues as weil as for 
glandularjsmooth muscle receptors in exocrine 
glands and smooth muscle, but a much lower affinity 
for cardiac receptors (Mutschler & Lambrecht, 1984; 
Waelbroeck et al., 1987b; Lambrecht et al., 1988a,c). 
In order to assess the structural requirements for the 
observed selectivity of 3a/ 3b, the binding character-
istics of a series of C/Si pairs structurally related to 
3aj3b were determined (compounds 1aj1b, 2a/2b, 4a/ 
4b--(jaj6b; Figure 1). Theseexperiments were carried 
out using a NB-OK 1 cell line (M 1 receptors type) 
and rat heart (cardiac receptors type) and pancreas 
(glandular/smooth muscle receptors type) homo-
genates (Waelbroeck et al., 1987a,b,c). Furthermore 
the binding affinities of compounds 1 aj 1 b--6aj6b to 
glandular/smooth muscle and cardiac receptor types 
were compared with the functional antimuscarinic 
properties in guinea-pig isolated ileum and atria. 
Atropine, pirenzepine and methoctramine were used 
as reference drugs. 
The experiments were carried out using the 
racemates of compounds 1 aj 1 b to 6a/6b but some 
data of functional experiments with the individual 
enantiomers of 5aj5b and 6aj6b have been published 
elsewhere (Tacke et al., 1986; 1987a) and binding 
studies are in progress. 
Metbods 
Radioligand binding studies 
Tissue preparations Male Wistar rats (200-250 g) 
were killed by decapitation and the pancreas and 
heart were immediately removed. 
The pancreas was minced with scissors and 
homogenized in 8 ml per pancreas of 300 mM sucrose · 
enriched with 0.2 mg ml- 1 bacitracin and 500 kalli-
krein inhibitor units ml- 1 of aprotinin, with a glass-
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Tefton homogenizer (7 up and down strokes). The 
resulting homogenate was filtered on two layers of 
medical gauze, and immediately diluted 11 fold with 
the incubation buffer (66 mM sodium phosphate 
buffer (pH 7.4) enriched with 2.6mM MgCI2 and 
with 1.32% bovine serum albumin, 0.24 mg ml- 1 
bacitracin and 600 kallikrein inhibitor units ml- 1 
aprotinin). 
The hearts were rinsed in isotonic NaCl, then 
homogenized in 2.5 ml of Tris-HCI buffer (pH 7.5) 
enriched with 250 mM sucrose, in an Ultraturrax 
homogenizer (5 s at maximum setting). The resulting 
homogenate was diluted 8 fold with the same buffer 
and filtered on two layers of medical gauze. 
NB-OK 1 cells were cultured in RPMI 1640 
medium, enriched with 10% foetal calf serum, 100 
units ml- 1 penicillin and 100 Jl8 ml- 1 Streptomycin, 
as described previously (Waelbroeck et al., 1988). 
For [ 3H]-N-methylscopolamine ([3H]-NMS) bind-
ing experiments, the cells were rinsed, detached and 
centrifuged in 20 mM sodium phosphate buffer 
(pH 7.4) containing 156 mM NaCI and 1 mM EDTA, 
resuspended and homogenized in 20mM Tris-HCl 
buffer (pH 7.5) enriched with 5 mM MgC12 and stored 
in liquid nitrogen. 
Binding experiments: On rat pancreas homogenates, 
1 ml of diluted homogenate (800 to 1000 J.tg protein 
per assay) was added to 200 J.tl of [3H]-NMS and 
unlabelled drugs (in water) to obtain final concentra-
tions of 50 mM sodium phosphate buffer (pH 7.4), 
2 mM MgC12 , 1% bovine serum albumin, 
0.2 mg ml- 1 bacitracin and 500 kallikrein inhibitor 
units ml- 1 of aprotinin. The [lH]-NMS concentra-
tion was 240pM (with a K 0 value of 120pM in 
pancreas). This inc~bation was prolonged for 4 h at 
25°C to allow equilibration of tracer binding to 
pancreas receptors (Waelbroeck et al., 1987b ). 
On rat cardiac homogenates, 80 J.tl of homogenate 
(400 to 500 J.tg of protein) was used per assay, in a 
total volume of 1.2 ml containing (final 
concentrations): 50mM sodium phosphate buffer 
(pH 7.4), 2 mM MgC12 , 1% bovine serum albumin, 
and the indicated concentrations of [ 3H]-NMS, and 
unlabelled drugs. The [ 3H]-NMS concentration was 
1.0 nM (with a K 0 value of 0.5 DM in heart). The incu-
bation period was 2 h at 25°C, sufficient to allow 
equilib_rium binding of [ 3H]-NMS in this tissue 
(Waelbroeck et al., 1987a,b). 
On human N B-0 K I homogenates, 80 J.tl of homo-
genate (80 Jl8 of protein) was used per assay, in a total 
volume of 1.2 ml containing (final concentrations): 
SO mM sodium phosphate buffer (pH 7 .4), 2 mM 
MgC12 , 1% bovine serum albumin, and the indi-
cated concentrations of [ 3H]-NMS, and unlabelled 
drugs. The [ 3H]-NMS concentration was 240pM 
(with a K 0 value of 120 pM in NB-OK 1 
homogenates). An incubation period of 2 h at 25°C 
was sufficient to allow equilibrium binding of [ 3H]-
NMS in this tissue (Waelbroeck et al., 1988). 
Non-specific [3H]-NMS binding, using pancreas, 
heart and NB-OK 1 homogenates was defined as 
[ 3H]-NMS binding in the presence of 1 JlM atropine. 
In our binding conditions, non-specific binding re-
presented less than 5% of total tracer binding, and 
was fully accounted for by binding to GF/C glass-
Iihre filters (see below). 
T o separate bound and free [ 3 H]-NM S, in pan-
creas, heart or NB-OK 1 homogenates, 2ml of ice-
cold 50mM sodium phospbate buffer (pH 7.4) was 
added to each sample, followed by immediate fil-
tration on GF /C glass-fibre filters (Whatman, Maid-
stone, Kent, England) presoaked overnight in 0.05% 
polyethyleneimine. The filters were rinsed three times 
with the same phospbate buffer, dried, and the radio-
activity counted by liquid scintillation. 
Analysis of binding data All competition curves 
were repeated at least three times, in duplicate. IC50 
values were determined by a computer-aided pro-
cedure described by Richardson & Humrich (1984), 
assuming the existence of only one receptor subtype. 
Experimental data points were within 3% of the 
expected values, assuming that the molecules investi-
gated competed with [3H]-NMS for binding to a 
single site. 
K1 values were determined from IC50 values, by 
the Cheng & Prusoff (1973) equation which assumes 
competitive inhibition of tracer binding to a single 
receptor subtype. The [3H]-NMS K0 value for the 
three systems investigated was determined in 
separate experiments, as described by Waelbroeck et 
al. (1987a,b; 1988). The pK1 values, indicated in 
Table 1, corresponded to -log K 1 values. 
The standard deviation of piC50 (-log IC50) 
determination was equal to or below 0.10 log unit. 
Repeated determinations of [3H]-NMS K 0 values 
were within 10% of each other. This error should be 
added to errors in IC50 determinations, since [ 3H]-
NMS K0 values were used to calculate pK1 values. 
We therefore estimated the standard deviation of 
pK1 values as being of approximately 0.15 log unit (40% of K 1 value). 
Pharmacological studies 
General considerations Guinea-pigs (300-450 g) of 
either sex were killed by cervical dislocation and the 
organs required were set up under 0.5 g tension in 
6 ml organ baths containing physiological salt solu-
tion (PSS) and gassed with 5% C02/95% 0 2 • The 
composition of PSS was as follows (IDM): NaCl 
137.0, KCl 2.7, CaC12 1.8, MgC12 1.05, NaHC03 
11.9, NaH2P04 0.42, glucose 5.6. All experiments 
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were conducted at pH 7.4, 32°C. Arecaidine propar-
gyl ester (Mutschler & Lambrecht, 1984; Barlow & 
Weston-Smith, 1985), except where indicated, was 
used as the agonist. 
After 1 h equilibration, concentration-response 
curves were obtained by cumulative addition of the 
agonists (van Rossum, 1963). When these responses 
were regular the tissues were exposed to a solutio~ of 
antagonist and each concentration of antagonistwas 
allowed to equilibrate before repeating the 
concentration-response curve. 
Guinea-pig isolated ileum Strips of ileallongitudinal 
muscle ( 1.5 cm) were prepared according to Paton & 
Zar (1968). Tissue responses were measured as iso-
tonic contractions with an electromechanical trans-
ducer connected to a Heilige amplifier and a 
Rikadenki recorder. The responses were then calcu-
lated as a percentage of the maximum response 
obtained to arecaidine propargyl ester and plotted 
against the logarithm of the agonist concentration, 
and EC50 values were determined for the control 
and the antagonist shifted concentration-response 
curves. 
Guinea-pig isolated atria Left atria were electrically 
paced, by use of platinum electrodes (2 H~ 3 ms 
duration, supramaximal voltage). Atrial responses to 
the agonists were measured as changes in isometric 
tension, and these effects were expressed as the per-
centage inhibition of the force of contraction. EC50 
values were determined as described for the ileum. 
Antagonist affinities ( pA2 ) Concentration-response 
curves were repeated in the presence of at least 3 
concentrations (log interval = 0.48) of antagonists, 
allowing 15-45 min equilibration time. Each concen-
tration of antagonist was tested 3 to 5 times and 
dose-ratios at EC50 values of agonists were calcu-
lated. These dose-ratios were pooled for each con-
centration of antagonist and the slope of the 
Arunlakshana and Schild plots were determined by 
linear regression using the method of least squares. 
pA2 values were estimated by fitting to the data the 
best straight line with a slope of unity (Arunlakshana 
& Schild, 1959; Tallarida et al., 1979). 
Statistical analysis The data are presented as 
means ± s.e.mean of n experiments. Differences 
between mean values were tested for statistical sig-
nificance by means of Student's t test, accepting 
P < 0.05 as being significant. 
Compounds 
[ 3H]-N-methylscopolamine ([3H]-NMS, 72 Ci 
mmol- 1) was obtained from Amersham Intematio-
nal (Bucks, England). Atropine, carbachol, bacitracin 
and polyethylenimine were purchased from Sigma 
Chemical Co. (St Louis, MO, U.S.A.). Aprotinin 
(Trasylol) was obtained from Bayer, Belgium. Piren-
zepine was a gift of Thomae (F.R.G.) and pro-
cyclidine (5a) was kindly provided by Deutsche 
Wellcome (F.R.G.). Methoctramine was kindly 
donated by Dr C. Melchiorre, University of 
Bologna, ltaly. Arecaidine propargyl ester was syn-
thesized in one of our laboratories (Mutschler & 
Hultzsch, 1973). 
Demethyl-hexocyclium [ 1-cyclohexyl-1-phenyl-2-
(1-methylpiperazin-4-yl)-1-ethanol, 1 a ], demethyl-
sila-hexocyclium [ cyclohexyl((1-methylpiperazin-4-
yl)methyl)phenylsilanol, 1 b ], hexocyclium methyl 
sulphate [ 4-(2-cyclohexyl-2-hydroxy-2-phenylethyl)-
1,1-dimethylpiperazinium methyl sulphate, 2a 
CH30S03 -], sila-hexocyclium methyl sulphate [4-((cyclohexylhydroxyphenylsilyl)methyl)-1, 1-dimethyl-
piperazinium methyl sulphate, 2b CH30S03 -], 
hexahydro-diphenidol hydrochloride [l-cyclohexyl-
1-phenyl-4-piperidino-1-butanol hydrochloride, 3a 
• HCI], hexahydro-sila-diphenidol hydrochloride 
[cyclohexylphenyl(3-piperidinopropyl)silanol hydro-
chloride, 3b ·HO], sila-procyclidine [cyclohexyl-
phenyl(2-pyrrolidinoethyl)silanol, 5b ], and 
tricyclamol chloride [1-(3-cyclohexyl-3-hydroxy-
3-phenylpropyl)-1-methylpyrrolidinium chloride, 6a 
a-] were prepared according to the literature: Ja 
and 2a CH30S03 - (Zaugg et al., 1958); lb and 2b 
CH30S03 - (Tacke et al., 1989); 3a • HCI and 3b 
• HCl (Tacke et al., 1985); 5b (Tacke et al., 1983; 
Tacke et al., 1987a); 6a Cl- (Murfitt, 1956). 
Synthetic chemistry N-methyl-hexahydro-dipheni-
dol iodide [ 1-(4-cyclohexyl-4-hydroxy-4-phenylbutyl)-
1-methylpiperidinium iodide, 4a 1-], N-methyl-
hexahydro-sila-diphenidol iodide [ 1-(3-( cyclo-
hexylhydroxyphenylsilyl)propyl)- 1 - methylpiperidin-
ium iodide, 4b 1-], and sila-tricyclamol iodide [1-
(2-((cyclohexylhydroxyphenyl)silyl)ethyl)- 1 - methyl-
pyrrolidinium iodide, 6b 1-] were prepared as 
follows: freshly distilled methyl iodide (18 mmol) was 
added under an atmosphere of dried nitrogen to a 
solution of 3a, 3b or 5b (8 mmol) in dry ethanol 
(50ml). After the reaction mixturewas stirred for 3 h 
at 30°C, dry n-pentane (75ml (Ja, 3b) andl50ml 
(5b), respectively) was added, and the mixture was 
stirred for 1.5 h at 20°C. Thereafter, the precipitate 
was collected by filtration and then recrystallized 
from ethanol/n-pentane. (After dissolving tbe precipi-
tate in dry ethanol, the fourfold (Ja, 3b) and twofold 
(5b) volume, respectively, of dry n-pentane was 
added dropwise to the solution). After drying the 
crystals in vacuo (because of their bygroscopic 
nature, the products 4b and 6b needed an especially 
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Table 1 Antagonist aßlnities (pK, values) 
obtained in [ 3H]-N-methylscopolamine ([3H]-
NMS) binding studies in NB-OK 1 (M 1 receptors), 
pancreas (glandular/smooth muscle rec::eptors) and 
cardiac (cardiac receptors) homogenates 
NB-OK 1 
Antagonist cells Pancreas Heart 
1 a Demethyl-hexocyclium 
I b Demethyl-sila-
hexocyclium 
2a Hexocyclium 
2b Sila-hexocyclium 
3a Hexahydro-diphenidol 
3b Hexahydro-sila-
diphenidol 
4a HHD methiodide 
4b HHSiD methiodide 
5a Procyclidine 
5b Sila-procyclidine 
6a Tricyclamol 
6b Sila-tricyclamol 
Atropine 
Pirenzepine 
Methoctramine 
8.0 
7.9 
8.8 
8.9 
7.9 
7.9 
8.5 
8.8 
8.1 
8.5 
8.9 
9.1 
9.5 
8.2 
7.3 
7.4 
7.4 
8.4 
8.4 
7.9 
7.8 
7.9 
8.2 
7.6 
7.9 
8.0 
8.2 
9.4 
6.8 
5.9 
The numbers show the mean estimate of the value 
of -log inhibitor constant (pKJ for n == 3 experi-
ments. The standard deviation was approximately 
0.15 log unit (see Methods). 
HH(Si)D methiodide = N-methyl-hexahydro-(sila-) 
diphenidol iodide. 
6.7 
6.6 
7.7 
7.6 
6.8 
6.8 
8.1 
8.0 
7.1 
7.4 
7.8 
8.0 
9.0 
6.5 
8.2 
careful drying) analytically pure products were 
obtained [characterized by 1H n.m.r., 13C n.m.r. and 
F AB MS measurements (data not given) as well as 
by eiemental analyses]. 
4a: C22H361NO (457.4}, yield 89%, m.p. 194°C; 
found: C, 57.8; H, 8.1; N, 3.1; calculated: C, 57.77; 
H, 7.93; N, 3.06%. 
4b: C11H36INOSi (473.5}, yield 65%, m.p. 119-
1210C; found: C, 53.3; H, 7.7; N, 3.1; calculated: C, 
53.27; H, 7.66; N, 2.96%. 
6b: C19H32INOSi (445.5), yield 92%, m.p. 128-
1290C; found: C, 51.6; H, 7.3; N, 3.1; calculated: C, 
51.23; H, 7.24; N, 3.14%. 
All antagonists studied were racemates. 
Results 
Radioligand binding studies in N B-0 K 1, heart and 
pancreas homogenates 
All compounds antagonized [3H]-NMS binding to 
musearlnie receptors. Competition curves with the 
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Figure l [ 3H]-N-methylscopolamine ([3H]-NMS) 
competition curves in human neuroblastoma NB-OK 1 
cells. [ 3H]-NMS binding to NB-OK 1 cells homoge-
nates was measured in the absence or presence of 1a 
(Ä), 2a (.6.), 3a (e). 4a (0) (top panel) or of the corre-
sponding sila-analogues 3b ( e), 4b ( 0), Sb (A) or 6b 
(.6.) (bottom panel), as indicated in Methods. Average of 
3 to 4 experiments performed in duplicate. 
C/Si pairs 1 a/ 1 b-6a/6b did not deviate significantly 
from results expected for competitive inhibition of 
tracer binding to a single receptor. Representative 
competition curves are shown in Figures 2 to 4 and 
pK1 values are given in Table 1. 
Atropine, pirenzepine and the quatemary com-
pounds 4aj4b and 6a/6b exhibited similar affinities 
for musearlnie receptors in pancreas and heart. 
At both receptors the following rank order of 
potencies was obtained: atropine > 4a/4b = 6a/ 
6b > pirenzepine. 
The aßinities obtained for compounds 1a/1b, 
2a/2b, 3a/3b and 5a/5b were significantly greater for 
receptors in pancreas as compared to receptors in 
heart, and the following rank orders of potencies 
were Öbtained; heart: 2a/2b > 5a/5b > 3a/3b ~ 1a/ 
1b; pancreas: 2a/2b > 3a/3b ~ 5a/5b ~ 1a/1b. In 
contrast, the pK1 value obtained for methoctramine 
was markedly lower in the pancreas as compared to 
heart. 
Pirenzepine, compounds 1 a/ 1 b, 2a/2b, 4a/4b, 
5a/5b, and 6a/6b recognized preferentially the recep-
tors expressed by NB-0 K 1 cells, as compared to 
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Figure 3 [ 3H]-N-methylscopolamine ([3H]-NMS) 
competition curves in rat heart. Details as in Figure 1, 
but with heart homogenates. 
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Fipre 4 [lH]-N-methylscopolamine ([lH]-NMS) 
competition curves in rat pancreas. Details as in Figure 
1, but with pancreas homogenates. 
heart and pancreas musearlnie receptors. The follow-
ing rank order of potencies was obtained: 6af6b, 
2a/2b, 4a/4b ~ pirenzepine = 5a/5b ;;;J!: la/lb. The fol-
lowing rank order of M 1 seleetivities (pK1 in NB-OK 
1 cells vs pKi in panereas) was obtained: 
pirenzepine > 6a/6b ~ 4a/4b ~ laflb = 5af5b ~ 2af2b. 
Methoctramine and 3a/3b presented a different 
selectivity pattern. Whereas methoetramine reeog-
nized the NB-OK 1 receptors with an affinity inter-
mediate between its affinity for cardiac and pancreas 
receptors, compounds 3a/3b exhibited the samehigh 
aßinity for NB-OK 1 and pancreas receptors and a 
much lower affinity for the receptors in the heart. 
I solated tissue experiments on atria and ileum from 
guinea-pig 
All compounds antagonized the negative inotropic 
effects in electrically stimulated atria and the con-
tractions of the ileum induced by arecaidine pro-
pargyl ester or carbachol. There was a 
concentration-dependent parallel shift to the right of 
agonist concentration-response curves without either 
basal tension or maximum response being affected. 
In all experlments Schild plots were linear through 
the eoncentration range tested for each antagonist, 
and slopes were not significantly different from unity 
(P > 0.05). Thus, all compounds were apparently 
simple competitive antagonists in both atrial and 
ileal preparations. The pA2 values are shown in 
Table 2. 
Atropine, pirenzepine and the quaternary eom-
pounds 4af4b and 6a/6b exhibited similar affinities 
for muscarinic receptors in ileum and atria. At both 
receptors the following rank order of potencies was 
obtained: atropine > 4a/4b ~ 6af6b > pirenzepine. 
The affinities obtained for compounds la/lb, 
2a/2b, 3a/3b, and 5a/5b were signifieantly greater at 
musearlnie receptors present in the ileum than at 
receptors in the atria, and the following rank orders 
of potencies were obtained; atria: 2aj2b > 5a/ 
5b ;;;J!: 3a/3b ~ laflb; ileum: 2a/2b > 3aj3b ;;;J!: 5a/ 
5b ;;;J!: Jaflb. 
In contrast, the pA2 value obtained for methoetra-
mine was much lower in the ileum eompared to the 
affinity obtained in the atria. 
Discamion 
This study has investigated the differences in affinity 
of a series of eompounds structurally related to 
hexahydro-diphenidol (3a) and hexahydro-sila-di-
phenidol (3b) at musearlnie receptors. The principal 
conclusions we draw from these experiments are: (1) 
the differences in affinity values exhibited by atro-
pine, pirenzepine, methoctramine and compounds 
1 af 1 b-6af6b and the different rank orders of anti-
SELECfiVE ANTAGONISTS AT MUSCARINIC RECEPTORS 203 
Table l Antagonist affmities (pA2 values) at ileal 
and atrial musearlnie receptors• 
Antagonist Ileum Atria 
1 a Demethyl-hexocyclium 7.63 ± 0.03 6.51 ± 0.08 
1 b Demethyl-sila- 7.87 ± 0.04 6.65 ± 0.04 
hexocyclium 
2a Hexocyclium 8.49 ± 0.04 7.75 ± 0.03 
2b Sila-hexocyclium 8.78 ± 0.05 7.57 ± 0.04 
3a Hexahydro-diphenidol 7.98 ± 0.02 6.71 ± 0.04 
3b Hexahydro-sila- 7.96 ± 0.04b 6.53 ± o.o5b 
diphenidol 
4a HHD methiodide 8.00 ± 0.03 7.93 ± 0.04 
4b HHSiD methiodide 8.18 ± 0.04 7.99 ± 0.02 
5a Procyclidine 7.75 ± 0.04• 6.76 ± 0.04• 
5b Sila-procyclidine 8.04 ± 0.04• 6.92 ± 0.04• 
6a Tricyclamol 7.92 ± 0.06• 7.65 ± o.o3• 
6b Sila-tricyclamol 8.22 ± o.o5• 7.88 ± o.o2• 
Atropine 8.85 ± 0.03 9.21 ± 0.04 
Pirenzepine 6.88 ± 0.04b 6.82 ± 0.03b 
Methoctramine 6.17 ± 0.05 7.69 ± 0.03 
The numbers show the mean estimate of the value 
of -log affinity constant (pA2 ± s.e.), n = 9-16 
experiments. • Arecaidine propargyl ester was used 
as the agonist in all cases, except carbachol. b Data 
previously published by Lambrecht et al., (1988a,b) 
musearlnie potencies confirm that NB-OK 1 cells, 
heart and pancreas possess different muscarinic 
receptors of the neuronal M 1, cardiac, and 
glandularjsmooth muscle subtypes, respectively 
(Waelbroeck et al., 1987a,b,c). (2) The rat heart and 
pancreas muscarinic binding sites are essentially 
similar to the musearlnie receptors mediating nega-
tive inotropic responses in guinea-pig atria and con-
tractions in guina-pig ileum, respectively. (3) 
Structural variations in the hexahydro-diphenidol 
(3a) and hexahydro-sila-diphenidol (3b) molecules 
Iead to new musearlnie antagonists which exhibit a 
different spectrum of selectivity from the parent com-
pounds. 
Comparison of binding and pharmacological 
experiments 
Atropine, pirenzepine, methoctramine and com-
pounds 1 af 11r6af6b showed qu~te wide variations in 
their affinities for the musearlnie receptors in panc-
reas, ileum and heart, their pKi (Table 1) and pA2 (Table 2) values differing by three orders of magni-
tude. The affinities of the antagonists for muscarinic 
receptors in rat pancreas and in guinea-pig ileum 
were very similar both individually and in rank 
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pKi in heart (~) or pancreas (A) 
homogenates from rat 
Fipre 5 Comparison of pK1 and pA2 values. pK1 
values obtained in binding experiments are compared 
with pA2 values obtained in pharmacological studies: 
data on rat cardiac homogenates are related to those on 
guinea-pig isolated atria (~). and rat pancreas homoge-
nates with guinea-pig isolated ileum strips (A) (data 
from Table 1 and 2). 
order. A highly significant correlation was found 
between these values (Figure 5). The affinities for 
muscarinic receptors in rat heart and guinea-pig 
atria were also strikingly similar (Figure 5), but they 
were different from those obtained in pancreas and 
ileum for most antagonists. This implies that the 
structural demands for the antagonists made by the 
muscarinic binding sites in pancreas and heart, 
respectively, are very similar to those made by the 
receptors in ileum and atria, respectively. 
Structure-selectivity relationships 
In the course of structure-activity relationship 
studies of compounds of the diphenidol type, it was 
found that replacement of the central carbinol 
carbon atom by silicon increased the affinity to 
muscarinic receptors in guinea-pig ileum and atria 
up to one order of magnitude (Tacke & Zilch, 1986; 
Tacke & Becker, 1987}. In contrast, sila-substitution 
of 1 af6a (-+ 1b/6b} bad little effect on the affinity in 
binding studies as weil as in pharmacological experi-
ments (Tables 1 and 2). This might be explained by 
differences in electronic and stereochemical proper-
lies: compounds of the diphenidol type carry two 
phenyl rings at the central C/Si atom, whereas in the 
case of 1 af 11r6af6b one phenyl ring is hydrogenated 
to a cyclohexyl ring system. 
The tertiary amines demethyl-hexocyclium (Ja), 
procyclidine (5a) and their silicon analogues (1b, 5b) 
l04 M. WAELBROECK et al. 
are musearlnie antagonists that possess a different 
selectivity profile from the parent eompounds 
hexahydro-diphenidol (Ja) and hexahydro-sila-di-
phenidol (Jb). The following aßinity rank orders at 
M 1, cardiac and glandularjsmooth muscle receptors 
were obtained; Ja/Jb: M 1 = glandular/smooth 
musele > eardiae; Jaflb, 5a/5b: M 1 > glandular/ 
smooth musele > eardiae. 
N-methylation of the tertiary amines lajlb, JajJb 
and 5a/5b increased the aßinity for cardiae as weil as 
for NB-0 K 1 cell M 1 receptors by up to one log unit 
(Tables 1 and 2). This also holds true for 1 af 1 b 
( -+2a/2b) at glandular/smooth muscle receptors in 
ileum and pancreas, wherea.S the affinity for 
glandular/smooth musele receptors of JajJb and 
5aj5b was not ehanged or only poorly inereased 
by N-methylation. Thus, the selectivity profiles of 
the quatemary compounds hexocyelium (2a) and 
sila-hexoeyelium (2b) are identieal to that of the 
tertiary amines 1ajlb {M 1 > glandular/smooth 
musele > cardiae), the aßinities of 2af2b being higher 
by about one order of magnitude than those of the 
tertiary eompounds 1 aj 1 b at the three subtypes. In 
eontrast, N-methylation of JajJb ( -+4a/4b) and 5a/5b 
( -+6a/6b) ehanged the receptor selectivity pattems of 
the tertiary amines. The following aflinity rank order 
was obtained; 4a/4b, 6a/6b: M 1 > glandular/smooth 
musele ~ eardiae. Thus, 4aj4b and 6aj6b show a 
selectivity profile that is qualitatively similar to that 
of pirenzepine. 
In eonelusion, the present study shows that on the 
basis of the binding profiles of pirenzepine, methoe-
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